Jeffrey Jones to United States
This is a "connection" page, showing publications Jeffrey Jones has written about United States.
Connection Strength
0.063
-
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Lancet Oncol. 2018 01; 19(1):65-75.
Score: 0.063